Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
7.26
+0.05 (0.69%)
At close: Jul 24, 2026, 4:00 PM EDT
7.05
-0.21 (-2.89%)
After-hours: Jul 24, 2026, 7:58 PM EDT

Aspire Biopharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
919----
Market Cap Growth
-53.69%-----
Enterprise Value
5.0522.820000
Last Close Price
7.26158.28----
PS Ratio
272.133005.84----
PB Ratio
0.310.89----
P/TBV Ratio
0.130.38----
EV/Sales Ratio
146.023679.05----
Debt / Equity Ratio
0.010.201.020.000-
Net Debt / Equity Ratio
0.020.201.02-0.040.05-
Net Debt / EBITDA Ratio
-0.18-0.37-1.05-0.010.51-
Net Debt / FCF Ratio
-0.08-0.85-4.78-0.020.35-
Asset Turnover
-0.01000-
Inventory Turnover
-0.05----
Quick Ratio
-0001.64-
Current Ratio
3.100.200.120.203.62-
Return on Equity (ROE)
-9.15%-221.36%-12.58%-0.87%-0.68%-
Return on Assets (ROA)
-65.75%-2650.58%-12.03%-0.84%-0.65%-
Return on Invested Capital (ROIC)
-58.35%-711.17%-11.43%-0.84%-0.65%-
Return on Capital Employed (ROCE)
1249.16%606.14%-13.12%-0.84%-0.65%-
Buyback Yield / Dilution
-222.62%-116.69%-1697.29%0.00%82.96%-
Total Shareholder Return
-222.62%-116.69%-1697.29%0.00%82.96%-
SEC Filings: 10-K · 10-Q